Skip to main content
. 2023 Oct 23;23:1017. doi: 10.1186/s12885-023-11485-y

Table 4.

Treatment emergent adverse events associated with sintilimab

Adverse Events Continue sintilimab group
(n = 47)
Any grade, n (%) Grade 3/4. n (%)
Fatigue 5 (10.6) 0
Pruritus 4 (8.5) 0
Elevated aspartate aminotransferase 4 (8.5) 2 (4.2)
Rash 3 (6.4) 1 (2.1)
Diarrhoea 2 (4.2) 0
Dysphonia 1 (2.1) 0
Nausea 1 (2.1) 0
Weight decreased 1 (2.1) 0
Alopecia 1 (2.1) 0
Decreased appetite 1 (2.1) 0